These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 120215

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Global and effective synergism of amikacin, gentamicin or tobramycin when combined with carbenicillin against Pseudomonas aeruginosa.
    Ximenes J, Hirai CK, Takenaka IM.
    J Int Med Res; 1979; 7(5):375-8. PubMed ID: 115732
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparative activity of netilmicin, gentamicin, amikacin, and tobramycin against Pseudomonas aeruginosa and Enterobacteriaceae.
    Briedis DJ, Robson HG.
    Antimicrob Agents Chemother; 1976 Oct; 10(4):592-7. PubMed ID: 825032
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of methods for assessing in vitro antibiotic synergism against Pseudomonas and Serratia.
    Weinstein RJ, Young LS, Hewitt WL.
    J Lab Clin Med; 1975 Nov; 86(5):853-62. PubMed ID: 810533
    [Abstract] [Full Text] [Related]

  • 7. In vitro activity, synergism, and testing parameters of amikacin, with comparisons to other aminoglycoside antibiotics.
    Kelly MT, Matsen JM.
    Antimicrob Agents Chemother; 1976 Mar; 9(3):440-7. PubMed ID: 1259402
    [Abstract] [Full Text] [Related]

  • 8. Comparative activity of tobramycin, amikacin, and gentamicin alone and with carbenicillin against Pseudomonas aeruginosa.
    Kluge RM, Standiford HC, Tatem B, Young VM, Greene WH, Schimpff SC, Calia FM, Hornick RB.
    Antimicrob Agents Chemother; 1974 Oct; 6(4):442-6. PubMed ID: 4157342
    [Abstract] [Full Text] [Related]

  • 9. Susceptibility of Pseudomonas aeruginosa to tobramycin or gentamicin alone and combined with carbenicillin.
    Anderson EL, Gramling PK, Vestal PR, Farrar WE.
    Antimicrob Agents Chemother; 1975 Sep; 8(3):300-4. PubMed ID: 810083
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vitro susceptibility of clinically important bacteria to amikacin: correlation of results of broth dilution and disk sensitivity tests and effect of medium composition.
    Linzenmeier G, Naumann P, Neussel H, Rosin H.
    J Infect Dis; 1976 Nov; 134 SUPPL():S262-70. PubMed ID: 825584
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effectiveness of carbenicillin - aminoglycoside and of cephalothin-aminoglycoside combinations against enterococci in vitro.
    Klastersky J, Daneau D.
    Pathol Biol (Paris); 1975 May; 23(5):345-8. PubMed ID: 1105331
    [Abstract] [Full Text] [Related]

  • 14. In vitro activity of ceftriaxone alone and in combination with gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa.
    Watanakunakorn C.
    Antimicrob Agents Chemother; 1983 Aug; 24(2):305-6. PubMed ID: 6314890
    [Abstract] [Full Text] [Related]

  • 15. Chemically defined antimicrobial susceptibility test medium for Pseudomonas aeruginosa.
    Jorgensen JH, Lee JC, Jones PM.
    Antimicrob Agents Chemother; 1977 Mar; 11(3):415-9. PubMed ID: 404961
    [Abstract] [Full Text] [Related]

  • 16. Effect of cation content of agar on the activity of gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa.
    Washington JA, Snyder RJ, Kohner PC, Wiltse CG, Ilstrup DM, McCall JT.
    J Infect Dis; 1978 Feb; 137(2):103-11. PubMed ID: 415096
    [Abstract] [Full Text] [Related]

  • 17. Tobramycin (nebramycin factor 6): in vitro activity against Pseudomonas aeruginosa.
    Meyer RD, Young LS, Armstrong D.
    Appl Microbiol; 1971 Dec; 22(6):1147-51. PubMed ID: 5002900
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Activity of amikacin, gentamicin and tobramycin combined with carbenicillin or ticarcillin against Pseudomonas aeruginosa in vitro.
    Meitert E, Petrescu AM, Chiru M.
    Arch Roum Pathol Exp Microbiol; 1985 Dec; 44(2):127-36. PubMed ID: 3938268
    [No Abstract] [Full Text] [Related]

  • 20. Synergy between cefotaxime, cefsulodin, azlocillin, mezlocillin and aminoglycosides against carbenicillin resistant or sensitive Pseudomonas aeruginosa.
    Perea EJ, Nogales MC, Aznar J, Martin E, Iglesias MC.
    J Antimicrob Chemother; 1980 Jul; 6(4):471-7. PubMed ID: 6253432
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.